Resonant Capital Advisors, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1803236 Madison, WI

Position in GILD

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$3,802,202

-$385,309 QoQ

Shares Held

30,095

+0.2% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.58%

of 13F equity value

Holder Rank

#648

of 2,266 holders

Holding Since

Jun 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Resonant Capital Advisors, LLC holds $36,919,957 across 13 Drug Manufacturers - General names. GILD ranks #6 (10.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	6,392	$7,666,757
2	AMGN	Amgen Inc	15,803	$5,722,582
3	JNJ	Johnson & Johnson	19,135	$4,859,715
4	ABBV	AbbVie Inc.	16,399	$4,126,644
5	MRK	Merck & Co., Inc.	31,697	$4,073,064
6	GILD	Gilead Sciences, Inc. This page	30,095	$3,802,202
7	BMY	Bristol Myers Squibb Co	49,118	$2,830,179
8	PFE	Pfizer Inc	52,773	$1,270,773

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,802,202	30,095	+0.2%	Shares	Sole	2026-07-27
2026-03-31	$4,187,511	30,046	+7.7%	Shares	Sole	2026-04-29
2025-12-31	$3,424,446	27,900	+14.3%	Shares	Sole	2026-01-29
2025-09-30	$2,708,400	24,400	+15.8%	Shares	Sole	2025-10-29
2025-06-30	$2,336,917	21,078	+11.5%	Shares	Sole	2025-07-31
2025-03-31	$2,118,753	18,909	+8.2%	Shares	Sole	2025-04-28
2024-12-31	$1,614,812	17,482	+16.2%	Shares	Sole	2025-01-24
2024-09-30	$1,261,037	15,041	+393.1%	Shares	Sole	2024-10-18
2024-03-31	$223,412	3,050	+12.6%	Shares	Sole	2024-05-01
2023-12-31	$219,375	2,708	+2.3%	Shares	Sole	2024-01-31
2023-06-30	$203,927	2,646	+12.2%	Shares	Sole	2023-07-25
2022-12-31	$202,434	2,358	-37.7%	Shares	Sole	2023-01-23
2022-09-30	$233,373	3,783	+12.5%	Shares	Sole	2022-10-20
2022-06-30	$207,805	3,362	—	Shares	Sole	2022-07-12
No filing history on record for this holder in this stock.